NO930406D0 - Spesifikke antistoffer mot aktiverte blodplater samt fremstilling - Google Patents

Spesifikke antistoffer mot aktiverte blodplater samt fremstilling

Info

Publication number
NO930406D0
NO930406D0 NO930406A NO930406A NO930406D0 NO 930406 D0 NO930406 D0 NO 930406D0 NO 930406 A NO930406 A NO 930406A NO 930406 A NO930406 A NO 930406A NO 930406 D0 NO930406 D0 NO 930406D0
Authority
NO
Norway
Prior art keywords
manufacturing
antibodies against
specific antibodies
activated blood
against activated
Prior art date
Application number
NO930406A
Other languages
English (en)
Other versions
NO930406L (no
Inventor
Klaus Bosslet
Gerhard Seemann
Beate Kehrel
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of NO930406D0 publication Critical patent/NO930406D0/no
Publication of NO930406L publication Critical patent/NO930406L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO93930406A 1992-02-07 1993-02-05 Spesifikke antistoffer mot aktiverte blodplater samt fremstilling derav NO930406L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4203545A DE4203545A1 (de) 1992-02-07 1992-02-07 Spezifische antikoerper gegen aktivierte plaettchen, ihre herstellung und ihre verwendung in diagnose und therapie

Publications (2)

Publication Number Publication Date
NO930406D0 true NO930406D0 (no) 1993-02-05
NO930406L NO930406L (no) 1993-08-09

Family

ID=6451181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930406A NO930406L (no) 1992-02-07 1993-02-05 Spesifikke antistoffer mot aktiverte blodplater samt fremstilling derav

Country Status (9)

Country Link
US (1) US5686583A (no)
EP (1) EP0554670B1 (no)
JP (1) JP3821858B2 (no)
AT (1) ATE205255T1 (no)
AU (1) AU669870B2 (no)
CA (1) CA2088889C (no)
DE (2) DE4203545A1 (no)
ES (1) ES2161698T3 (no)
NO (1) NO930406L (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034904B2 (en) * 2002-06-14 2011-10-11 Immunogen Inc. Anti-IGF-I receptor antibody
US7538195B2 (en) * 2002-06-14 2009-05-26 Immunogen Inc. Anti-IGF-I receptor antibody
US7655411B2 (en) * 2002-08-23 2010-02-02 W2 Holdings, Inc. Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610960A (en) * 1983-12-21 1986-09-09 Wisconsin Alumni Research Foundation Monoclonal antibody to thrombospondin and method for assaying for and isolating thrombospondin
EP0387380A1 (en) * 1989-03-17 1990-09-19 BEHRINGWERKE Aktiengesellschaft Mutants of urinary plasminogen activator, their production and use
AU6964891A (en) * 1989-11-03 1991-05-31 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Novel monoclonal antibody against human platelets
US5192744A (en) * 1990-01-12 1993-03-09 Northwestern University Method of inhibiting angiogenesis of tumors
US5200397A (en) * 1990-02-22 1993-04-06 W. R. Grace & Co.-Conn. Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
WO1992017499A1 (en) * 1991-04-08 1992-10-15 Cornell Research Foundation, Inc. A unique hexapeptide derived from thrombospondin and its uses
CA2063055A1 (en) * 1991-05-22 1992-11-23 Jacob Eyal Peptides having thrombospondin-like activity and their therapeutic use

Also Published As

Publication number Publication date
EP0554670A3 (en) 1994-07-13
AU3283693A (en) 1993-08-12
EP0554670B1 (de) 2001-09-05
DE4203545A1 (de) 1993-08-12
ES2161698T3 (es) 2001-12-16
CA2088889C (en) 2009-08-25
DE59310204D1 (de) 2001-10-11
EP0554670A2 (de) 1993-08-11
US5686583A (en) 1997-11-11
CA2088889A1 (en) 1993-08-08
AU669870B2 (en) 1996-06-27
NO930406L (no) 1993-08-09
ATE205255T1 (de) 2001-09-15
JP3821858B2 (ja) 2006-09-13
JPH06133768A (ja) 1994-05-17

Similar Documents

Publication Publication Date Title
DE69636748D1 (de) Bispezifischer antikörper zur effektiven behandlung von b-zell lymphomen und zellinien
NO943625D0 (no) Monoklonale antistoffer mot interferonreseptoren med nöytraliserende aktivitet mot type-I-interferon
PT733069E (pt) Antigenios ctla-8 de primata purificados e reagentes relacionados
ATE510854T1 (de) Lineares, schweres antikörperkettenfragment vh- ch1-vh-ch1
CA2130436A1 (en) Cloning and expression of humanized monoclonal antibodies against human interleukin-4
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
CO4480111A1 (es) Anticuerpos monoclonales de mono especificos para humanos b7. y/o b7.2, formas primatizadas de los mismos, composicio- nes farmaceuticas que los contienen, y uso de los mismos co- mo inmunosupresantes
ATE301471T1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
DE69532889D1 (de) Interleukin-5-spezifische rekombinante antikörper
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
AU628948B2 (en) Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof
FI873553A7 (fi) HIV-infektioiden hoitoon ja diagnostisointiin käyttökelpoisia monoklonaalisia vasta-aineita ja peptidejä
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
ATE159300T1 (de) Monoklonale antikörper gegen menschliches ige
DK0749481T3 (da) Humaniserede monoklonale antistoffer mod human interleukin-4
IT1231727B (it) Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
NO930406D0 (no) Spesifikke antistoffer mot aktiverte blodplater samt fremstilling
EP0215131A4 (en) ANTIGEN E87Ag OF PSEUDOMONAS AERUGINOSE, MONOCLONAL ANTIBODIES AGAINST THIS ANTIGEN AND HYBRIDOMA.
FI934963A7 (fi) CTAA 81AV78, monoklonaalisen 81AV78-humaanivasta-aineen tunnistama ant igeeni
DE3851855D1 (de) Gegen die Gamma-Kette des T-Zell-Rezeptors gerichteter monoklonaler Antikörper.
DE3687542D1 (de) Monoklonaler antikoerper gegen humanes protein c.
EP0450573A3 (en) Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
RU96123360A (ru) Способ лечения сепсиса у новорожденных
NO903788D0 (no) Monoklonalt antistoff mot protein c.